All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practiceJuan Berenguer, Juan González‐García, Ana Moreno et al.|Hepatology|2018Cited by 79
Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be SignificantJuan Berenguer, Inmaculada Jarrín, Leire Pérez‐Latorre et al.|Open Forum Infectious Diseases|2018Cited by 28